Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Kit, Immunochromatographic, Bacillus Anthracis Differential Antibody

FDA product code NPO · 1 cleared devices

Class 2 Microbiology
Regulation
21 CFR 866.3045
Review panel
MI
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
2003-12-09 – 2003-12-09

A serological reagent to distinguish b. Anthracis culture growth from other bacillus spp. Growth

↑